1.
Cardiovascular Toxicity of Nicotine: Implications for Electronic Cigarette Use
by Benowitz, Neal L
Trends in cardiovascular medicine, 2016, Vol.26 (6), p.515-523
2.
Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participan...
by Lorenz, Matthias W, Dr
The Lancet (British edition), 2012, Vol.379 (9831), p.2053-2062
3.
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
by Dehghan, Mahshid
The Lancet (British edition), 2017-11-04, Vol.390 (10107), p.2050-2062
4.
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
by Rapsomaniki, Eleni, Dr
The Lancet (British edition), 2014, Vol.383 (9932), p.1899-1911
5.
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
by Tawakol, Ahmed, Dr
The Lancet (British edition), 2017, Vol.389 (10071), p.834-845
6.
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
by Leong, Darryl P, Dr
The Lancet (British edition), 2015, Vol.386 (9990), p.266-273
7.
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S
Nature medicine, 2019-11, Vol.25 (11), p.1753-1760
8.
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
by Miranda, J Jaime
Nature medicine, 2019-11, Vol.25 (11), p.1667-1679
9.
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
by Mahmood, Syed S, MD
The Lancet (British edition), 2014, Vol.383 (9921), p.999-1008
10.
The role of uric acid in the pathogenesis of human cardiovascular disease
by Kanbay, Mehmet
Heart, 2013-06, Vol.99 (11), p.759-766
11.
Computational fluid dynamics modelling in cardiovascular medicine
by Morris, Paul D
Heart, 2016-01, Vol.102 (1), p.18-28
12.
The epidemiology of cardiovascular disease in the UK 2014
by Bhatnagar, Prachi
Heart, 2015-08, Vol.101 (15), p.1182-1189
13.
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
by Mars, Nina
Nature medicine, 2020-04, Vol.26 (4), p.549-557
14.
Trends in the epidemiology of cardiovascular disease in the UK
by Bhatnagar, Prachi
Heart (British Cardiac Society), 2016-12, Vol.102 (24), p.1945-1952
15.
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiologica...
by Yusuf, Salim, Prof
The Lancet (British edition), 2011, Vol.378 (9798), p.1231-1243
16.
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
by Pavo, Noemi
Heart (British Cardiac Society), 2015-12, Vol.101 (23), p.1874-1880
17.
Lung function and cardiovascular disease: A link
by Ramalho, Sergio H.R
Trends in cardiovascular medicine, 2021-02, Vol.31 (2), p.93-98
18.
State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease
by Cohen, Beth E
American journal of hypertension, 2015-11, Vol.28 (11), p.1295-1302
19.
Bariatric surgery and cardiovascular outcomes: a systematic review
by Vest, Amanda R
Heart, 2012-12, Vol.98 (24), p.1763-171
20.
Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis
by Kramer, Caroline K
Diabetologia, 2019-03-07, Vol.62 (6), p.905-914
